NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
5
As on 5th Dec 2025 004310 STOCK Price closed @ 5060.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3595.28 & Strong Buy for SHORT-TERM with Stoploss of 3561.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 4200.00 Change Price %
High 5060.00 1 Day 1165.00 29.91
Low 4050.00 1 Week 1445.00 39.97
Close 5060.00 1 Month 1295.00 34.40
Volume 16827426 1 Year 1420.00 39.01
52 Week High 5060.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
001520 881.00 10.68%
001520 881.00 10.68%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
002995 14090.00 29.98%
002995 14090.00 29.98%
002995 14090.00 29.98%
084670 27750.00 29.98%
084670 27750.00 29.98%
001260 10060.00 29.97%
001260 10060.00 29.97%
005965 19950.00 29.97%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE7006.27
RESISTANCE6382.09
RESISTANCE5996.27
RESISTANCE5610.45
SUPPORT4509.55
SUPPORT4123.73
SUPPORT3737.91
SUPPORT3113.73
 
004310 Forecast December 2025
4th UP Forecast6678.68
3rd UP Forecast6159.56
2nd UP Forecast5838.68
1st UP Forecast5517.8
1st DOWN Forecast4602.2
2nd DOWN Forecast4281.32
3rd DOWN Forecast3960.44
4th DOWN Forecast3441.32
 
004310 Weekly Forecast
4th UP Forecast6678.68
3rd UP Forecast6159.56
2nd UP Forecast5838.68
1st UP Forecast5517.80
1st DOWN Forecast4602.20
2nd DOWN Forecast4281.32
3rd DOWN Forecast3960.44
4th DOWN Forecast3441.32
 
004310 Forecast2025
4th UP Forecast9039.26
3rd UP Forecast7763.09
2nd UP Forecast6974.26
1st UP Forecast6185.43
1st DOWN Forecast3934.58
2nd DOWN Forecast3145.75
3rd DOWN Forecast2356.92
4th DOWN Forecast1080.75
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service